European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N; ESC Scientific Document Group.
Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246.
Quality of Life and Type of Cardiac Resynchronization Therapy Device in Older Heart Failure Patients.
Dhande M, Myaskovsky L, Althouse A, Singh M, Weiss R, Shalaby A, Al-Khatib SM, Topoll A, Jain S, Saba S.
J Palliat Med. 2023 Apr;26(4):481-488. doi: 10.1089/jpm.2022.0217. Epub 2022 Nov 8.
The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Gonzalez J, Caballero-Estevez N, Martín-Casañas FV, Lara-Padron A, Aranda JM Jr.
Europace. 2015 Apr;17(4):598-602. doi: 10.1093/europace/euu333. Epub 2015 Jan 6.
Preimplantation AI-ECG Age as a Predictor of Survival Following Cardiac Resynchronization Therapy.
Gupta AR, Kumar A, Cao JJL, Harmon DM, Friedman PA, Attia Z, Noseworthy PA, Madhavan M, Siontis KC, Sugrue A, Tan NY, Killu AM, Ezzeddine FM, DeSimone CV, Lopez-Jimenez F, Del-Carpio Munoz F, de Melo JF Jr, Liu X, Mulpuru S, Rodriguez V, Asirvatham S, Kowlgi GN, Cha YM, Lee JZ, Deshmukh AJ.
JACC Clin Electrophysiol. 2025 Dec 24:S2405-500X(25)00996-X. doi: 10.1016/j.jacep.2025.11.014. Online ahead of print.
Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature.
Zhu J, Yang Q, Pan J, Shi H, Jin B, Chen Q.
BMC Cardiovasc Disord. 2019 Mar 5;19(1):53. doi: 10.1186/s12872-019-1028-0.
Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support.
Lim K, Choi JO, Yang JH, Park SJ, Kim SH, Kang J, Joh HS, Shin SH.
Korean Circ J. 2017 Jan;47(1):132-135. doi: 10.4070/kcj.2016.0176. Epub 2016 Dec 23.
Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W.
J Am Coll Cardiol. 2011 Aug 9;58(7):729-37. doi: 10.1016/j.jacc.2011.04.024.
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Sághy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N.
Eur Heart J. 2020 Jun 1;41(21):2012-2032. doi: 10.1093/eurheartj/ehaa010.
Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients.
Jeevanantham V, Turagam M, Shanberg D, Reddy M, Atoui M, Daubert JP, Dawn B, Lakkireddy D.
Indian Pacing Electrophysiol J. 2016 Jul-Aug;16(4):115-119. doi: 10.1016/j.ipej.2016.11.006. Epub 2016 Nov 11.
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.
Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC.
Eur J Heart Fail. 2019 Sep;21(9):1093-1102. doi: 10.1002/ejhf.1552. Epub 2019 Jul 29.
